Cargando…

Conventional Prostheses versus Sutureless Perceval for Aortic Valve Replacement: A Meta-Analysis

Purpose: Perceval sutureless valves have gained popularity. Whether this implant performs superior to the traditional sutured prosthesis remains unclear. This meta-analysis compared the Perceval implants versus the sutured conventional valves for aortic valve replacement (AVR). Methods: This meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Colarossi, Giorgia, Migliorini, Filippo, Becker, Michael, Arias, Jessica P, Autschbach, Ruediger, Moza, Ajay, Aljalloud, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284666/
https://www.ncbi.nlm.nih.gov/pubmed/36517036
http://dx.doi.org/10.5761/atcs.ra.22-00125
Descripción
Sumario:Purpose: Perceval sutureless valves have gained popularity. Whether this implant performs superior to the traditional sutured prosthesis remains unclear. This meta-analysis compared the Perceval implants versus the sutured conventional valves for aortic valve replacement (AVR). Methods: This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The following databases were accessed: PubMed, Google Scholar, Web of Science, Scopus, and EMBASE. All clinical investigations comparing Perceval versus the conventional prostheses for AVR were considered. Results: The Perceval group demonstrated higher rate of pacemaker implantation (P <0.00001). Aortic cross-clamp (ACC) time (P <0.00001) and cardiopulmonary bypass (CPB) time (P <0.00001) were shorter in the Perceval group. Similarity was found in mean and peak pressure gradient (P = 0.8 and P = 0.2, respectively), mean aortic valve area (P = 0.3), length of intensive care unit (P = 0.4) and hospital stay (P = 0.2), rate of revision (P = 0.11), hemorrhages (P = 0.05), paravalvular leak (P = 0.3), cerebrovascular complication (P = 0.7), and early mortality (P = 0.06). Conclusion: Given the shorter ACC time and CPB time, Perceval AVR can be an alternative in high-risk patients. The higher rate of pacemaker implantation following Perceval may limit its routine implantation.